Effect of medication education on knowledge, attitude and accepting psychiatric patients
- Conditions
- Condition 1: psychosis. Condition 2: Psychosis. Condition 3: Psychosis. Condition 4: Psychosis. Condition 5: Psychosis.SchizophreniaSchizotypal DisorderSchizoaffective DisorderBipolar Affective disorderDepressive episode
- Registration Number
- IRCT2017071033378N4
- Lead Sponsor
- Research and Technology Vice chancellor Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 78
Inclusion Criteria: According to the physician's diagnosis and patient's records, lack of mental retardation; not being in acute conditions of psychosis; literacy; ability to sit in the chair for a maximum of 60 minutes; verbal communication ability; being older than 18 years old; at least one hospitalization record due to the recurrence of disease; mental disorder shouldn’t be due to substance abuse and psychotropic drugs.
Exclusion criteria: in each stage patient reluctance to continue the study; existence of patient in acute conditions of psychosis; patients who will be discharged before the completion of study by the physician permission or with personal consent; patients who think about suicide during the study; absence of patient in one of the training sessions.
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Knowledge. Timepoint: Before intervention, immediately after the intervention. Method of measurement: Knowing About Medication Questionnaire (KAM).;Attitude. Timepoint: Before intervention, immediately after the intervention. Method of measurement: Drug Attitude Questionnaire.
- Secondary Outcome Measures
Name Time Method Accepting Medication. Timepoint: Before intervention, immediately after the intervention. Method of measurement: Accepting Medication Check List.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.